Kenya’s Ministry of Health has announced a temporary shortage of the rotavirus vaccine, which is used to protect infants from severe diarrhoea and dehydration. The vaccine is normally given to babies at six, ten, and fourteen weeks as part of the country’s routine immunisation programme.
Health Cabinet Secretary Aden Duale explained that the shortage affects the Rotavac Frozen vaccine. The problem began after the manufacturer, Bharat Biotech, reported delays in production because its facilities are being upgraded. The delay has affected vaccine deliveries in many countries and is expected to continue between 2026 and 2027.
As of early March 2026, Kenya had only about 4,000 doses of the vaccine remaining at the national level. Health officials estimate that this supply may last less than one month. A shipment that was expected in January has also been delayed, and the next delivery is now expected by the end of April.
The Ministry of Health is working with partners such as UNICEF to speed up deliveries and distribute the remaining doses fairly across counties. Officials are also closely monitoring vaccine stocks to reduce disruptions to immunisation services.
Despite the shortage, parents are encouraged to continue taking their children for routine vaccinations. Health authorities have also urged families to follow preventive measures such as regular handwashing, safe drinking water, proper food handling, and maintaining clean environments.
The government has assured the public that protecting children’s health remains a top priority and that efforts are underway to restore normal vaccine supplies as soon as possible.
